Table 1.
Primary ophthalmic diseases of patients in numbers and percentage for each priority group.
| Primary Ophthalmic Diseases | Priority 1 (n) (%) |
Priority 2 (n) (%) |
Priority 3 (n) (%) |
|---|---|---|---|
| nAMD | 296 (49.6) | 57 (51.8) | 8 (22.2) |
| BRVO, CRVO | 115 (19.3) | 18 (16.4) | 6 (16.7) |
| DME (NPDR and PDR) | 98 (16.4) | 24 (21.8) | 17 (47.2) |
| Secondary CNV | 35 (5.9) | 5 (4.6) | 1 (2.8) |
| Myopic CNV | 22 (3.6) | 3 (2.7) | 1 (2.8) |
| Other | 31 (5.2) | 3 (2.7) | 3 (8.3) |
| Total | 597 (100) | 110 (100) | 36 (100) |
Abbreviations: nAMD: neovascular age-related macular degeneration; BRVO: branch retinal vein occlusion; CRVO: central retinal vein occlusion; myopic CNV: myopic choroidal neovascularization; secondary CNV: secondary choroidal neovascularization, other than AMD or myopia-related; DME: diabetic macular edema; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy.